Lower Urinary Tract Symptoms Clinical Trial
Official title:
Effect of Need to Void on Parkinsonian Gait
Verified date | September 2019 |
Source | Pierre and Marie Curie University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
This study evaluates the effect of the need to void on parkinsonian gait
Status | Completed |
Enrollment | 11 |
Est. completion date | December 30, 2017 |
Est. primary completion date | December 28, 2017 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 99 Years |
Eligibility |
Inclusion Criteria: - Parkinsonian syndromes - Follow in neurourology for Lower urinary tract symptoms - Able to walk 50 meters without human assistance - able to hold voiding for more than 3 minutes Exclusion Criteria: - Actual urinary tract infection - Montreal cognitive assessment < 20/30 - Acute psychiatric or neurologic disorders who can interfer with walking tests |
Country | Name | City | State |
---|---|---|---|
France | Service de Neuro-urology, hôpital Tenon | Paris |
Lead Sponsor | Collaborator |
---|---|
Pierre and Marie Curie University |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Gait Speed | Gait speed calculated from 10 meter walk test. Time is recorded by a manual chronometer. 3 records are done, mean time is calculated. | [Time Frame: 1 Day: at strong desire to void and just after void] | |
Secondary | Time for Timed up and Go | 1 record is done for timed up and go test. Time is recorded by a manual chronometer | [Time Frame: 1 Day: at strong desire to void and just after void] | |
Secondary | Time for GMT | 1 record is done for GMT , time is recorded by a manual chronometer | [Time Frame: 1 Day: at strong desire to void and just after void] | |
Secondary | Variation of gait speed | Standard deviation and Coefficient of variation is calculated from the 3 records of 10 meter walk test. | [Time Frame: 1 Day: at strong desire to void and just after void] |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04856748 -
Nomogram to Diagnose Prostatic Inflammation (PIN) in Men With Lower Urinary Tract Symptoms
|
||
Completed |
NCT03623880 -
Enhancing Behavioral Treatment for Women With Pelvic Floor Disorders
|
N/A | |
Enrolling by invitation |
NCT06317116 -
Examining the Relationship Between Core Muscles and Bladder Issues in Children
|
||
Completed |
NCT03625843 -
Mindfulness Exercises to Reduce Anxiety and Pain During Urodynamic Testing
|
N/A | |
Recruiting |
NCT05814614 -
Bladder Complaints in Parkinson's Disease Effectiveness of Pelvic Floor Muscle Exercises and Electrical Stimulation
|
N/A | |
Recruiting |
NCT04288427 -
5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy
|
N/A | |
Not yet recruiting |
NCT06452927 -
EEP in Patients With Urodynamically Proven DU/DA
|
N/A | |
Completed |
NCT02330107 -
Auriculotherapy on Lower Urinary Tract Symptoms in Elderly Men
|
N/A | |
Completed |
NCT03339609 -
Uroflow Measurement With Electromyography (EMG) to Identify Lower Urinary Tract Symptoms (LUTS): Conducted on Healthy Children
|
N/A | |
Terminated |
NCT02003742 -
Efficacy and Safety of a Single TRUS-guided Intraprostatic Injection of NX-1207 in Patients With LUTS Due to BPH
|
Phase 3 | |
Terminated |
NCT01003249 -
Dysfunctional Voiding and Lower Urinary Tract Symptoms With Baclofen
|
Phase 4 | |
Completed |
NCT01078545 -
Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Prostate Cancer and Lower Urinary Tract Symptoms (LUTS)
|
N/A | |
Completed |
NCT02074644 -
Clinical Trial of Prostatic Arterial Embolization Versus a Sham Procedure to Treat Benign Prostatic Hyperplasia
|
N/A | |
Recruiting |
NCT03802851 -
HoLEP Prior to Radiation Therapy for Patients With LUTS/Retention and Concurrent Prostate Cancer
|
N/A | |
Active, not recruiting |
NCT05415748 -
Deprescribing Tamsulosin in Older Men
|
Phase 4 | |
Recruiting |
NCT05702294 -
Electronic Urinary Flowmeter to Improve Accuracy of Bladder Diaries .
|
N/A | |
Enrolling by invitation |
NCT05537272 -
The Efficacy of Tamsulosin and Tadalafil Compared to Placebo in the Treatment and Prevention of Urinary Disorders After Transperineal Prostate Biopsy
|
Phase 4 | |
Recruiting |
NCT05826691 -
Benign Prostate Surgery and QOL and Sexual Function
|
||
Completed |
NCT04104100 -
Prevalence and Risk Factor of NP in Women With LUTS
|
||
Completed |
NCT04190641 -
Single-use Cystoscope System for Direct Visualization of the Urethra and Bladder
|
N/A |